Role of the Microbiome in Immunotherapy of Melanoma

被引：2

作者：

Jiminez, Victoria ^{[1
]}

Yusuf, Nabiha ^{[2
,3
]}

机构：

[1] Univ Alabama Birmingham, Heersink Sch Med, Birmingham, AL USA

[2] Univ Alabama Birmingham, Heersink Sch Med, Dept Dermatol, Birmingham, AL USA

[3] Univ Alabama Birmingham, Dept Dermatol, 1670 Univ Blvd VH566A, Birmingham, AL 35294 USA

来源：

CANCER JOURNAL | 2023年 / 29卷 / 02期

关键词：

Artificial intelligence; bacterial colonization; gut microbiome; immune checkpoint inhibitors; immunotherapy; melanoma; skin-gut axis; STAGE-III; ADJUVANT IPILIMUMAB; ANTITUMOR IMMUNITY; COMPLETE RESECTION; GUT MICROBIOTA; DOUBLE-BLIND; DISSECTION; PROBIOTICS; NIVOLUMAB; EFFICACY;

D O I：

10.1097/PPO.0000000000000648

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Novel immunotherapeutics for advanced melanoma have drastically changed survival rates and management strategies in recent years. Immune checkpoint inhibitors have emerged as efficacious agents for some patients but have not been proven to be as beneficial in other patient cohorts. Recent investigation into this observation has implicated the gut microbiome as a potential immunomodulator in regulating patient response to therapy. Numerous studies have provided evidence for this link. Bacterial colonization patterns have been associated with therapeutic outcomes, under the notion that favorable commensal organisms improve host immune response. This review aims to report the most recent and pertinent findings related to the relationship between gut microbial communities and melanoma therapy efficacy. This article also highlights the emerging frontier of artificial intelligence in its application regarding patient microbial composition evaluation, predictive models for therapy response, and recommendations for the future of probiotics and dietary interventions to optimize melanoma survival and outcomes.

引用

页码：70 / 74

页数：5

共 38 条

[1] Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients [J].

Baruch, Erez N. ;

Youngster, Ilan ;

Ben-Betzalel, Guy ;

Ortenberg, Rona ;

Lahat, Adi ;

Katz, Lior ;

Adler, Katerina ;

Dick-Necula, Daniela ;

Raskin, Stephen ;

Bloch, Naamah ;

Rotin, Daniil ;

Anafi, Liat ;

Avivi, Camila ;

Melnichenko, Jenny ;

Steinberg-Silman, Yael ;

Mamtani, Ronac ;

Harati, Hagit ;

Asher, Nethanel ;

Shapira-Frommer, Ronnie ;

Brosh-Nissimov, Tal ;

Eshet, Yael ;

Ben-Simon, Shira ;

Ziv, Oren ;

Khan, Md Abdul Wadud ;

Amit, Moran ;

Ajami, Nadim J. ;

Barshack, Iris ;

Schachter, Jacob ;

Wargo, Jennifer A. ;

Koren, Omry ;

Markel, Gal ;

Boursi, Ben .

SCIENCE, 2021, 371 (6529) :602-+

[2] Role of gut microbiome on immunotherapy efficacy in melanoma [J].

Bibbo, Stefano ;

Ianiro, Gianluca ;

Giambo, Federica ;

Settanni, Carlo Romano ;

Cammarota, Giovanni ;

Gasbarrini, Antonio .

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (03)

[3] Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab [J].

Chaput, N. ;

Lepage, P. ;

Coutzac, C. ;

Soularue, E. ;

Le Roux, K. ;

Monot, C. ;

Boselli, L. ;

Routier, E. ;

Cassard, L. ;

Collins, M. ;

Vaysse, T. ;

Marthey, L. ;

Eggermont, A. ;

Asvatourian, V. ;

Lanoy, E. ;

Mateus, C. ;

Robert, C. ;

Carbonnel, F. .

ANNALS OF ONCOLOGY, 2017, 28 (06) :1368-1379

[4] Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer [J].

Derosa, L. ;

Hellmann, M. D. ;

Spaziano, M. ;

Halpenny, D. ;

Fidelle, M. ;

Rizvi, H. ;

Long, N. ;

Plodkowski, A. J. ;

Arbour, K. C. ;

Chaft, J. E. ;

Rouche, J. A. ;

Zitvogel, L. ;

Zalcman, G. ;

Albiges, L. ;

Escudier, B. ;

Routy, B. .

ANNALS OF ONCOLOGY, 2018, 29 (06) :1437-1444

[5] Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial [J].

Eggermont, Alexander M. M. ;

Chiarion-Sileni, Vanna ;

Grob, Jean-Jacques ;

Dummer, Reinhard ;

Wolchok, Jedd D. ;

Schmidt, Henrik ;

Hamid, Omid ;

Robert, Caroline ;

Ascierto, Paolo Antonio ;

Richards, Jon M. ;

Lebbe, Celeste ;

Ferraresi, Virginia ;

Smylie, Michael ;

Weber, Jeffrey S. ;

Maio, Michele ;

Hosein, Fareeda ;

de Pril, Veerle ;

Kicinski, Michal ;

Suciu, Stefan ;

Testori, Alessandro .

EUROPEAN JOURNAL OF CANCER, 2019, 119 :1-10

[6] Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma [J].

Eggermont, Alexander M. M. ;

Blank, Christian U. ;

Mandala, Mario ;

Long, Georgina, V ;

Atkinson, Victoria ;

Dalle, Stephane ;

Haydon, Andrew ;

Lichinitser, Mikhail ;

Khattak, Adnan ;

Carlino, Matteo S. ;

Sandhu, Shahneen ;

Larkin, James ;

Puig, Susana ;

Ascierto, Paolo A. ;

Rutkowski, Piotr ;

Schadendorf, Dirk ;

Koornstra, Rutger ;

Hernandez-Aya, Leonel ;

Maio, Michele ;

van den Eertwegh, Alfonsus J. M. ;

Grob, Jean-Jacques ;

Gutzmer, Ralf ;

Jamal, Rahima ;

Lorigan, Paul ;

Ibrahim, Nageatte ;

Marreaud, Sandrine ;

van Akkooi, Alexander C. J. ;

Suciu, Stefan ;

Robert, Caroline .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (19) :1789-1801

[7] Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial [J].

Eggermont, Alexander M. M. ;

Chiarion-Sileni, Vanna ;

Grob, Jean-Jacques ;

Dummer, Reinhard ;

Wolchok, Jedd D. ;

Schmidt, Henrik ;

Hamid, Omid ;

Robert, Caroline ;

Ascierto, Paolo A. ;

Richards, Jon M. ;

Lebbe, Celeste ;

Ferraresi, Virginia ;

Smylie, Michael ;

Weber, Jeffrey S. ;

Maio, Michele ;

Konto, Cyril ;

Hoos, Axel ;

de Pril, Veerle ;

Gurunath, Ravichandra Karra ;

de Schaetzen, Gaetan ;

Suciu, Stefan ;

Testori, Alessandro .

LANCET ONCOLOGY, 2015, 16 (05) :522-530

[8] Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma [J].

Faries, M. B. ;

Thompson, J. F. ;

Cochran, A. J. ;

Andtbacka, R. H. ;

Mozzillo, N. ;

Zager, J. S. ;

Jahkola, T. ;

Bowles, T. L. ;

Testori, A. ;

Beitsch, P. D. ;

Hoekstra, H. J. ;

Moncrieff, M. ;

Ingvar, C. ;

Wouters, M. W. J. M. ;

Sabel, M. S. ;

Levine, E. A. ;

Agnese, D. ;

Henderson, M. ;

Dummer, R. ;

Rossi, C. R. ;

Neves, R. I. ;

Trocha, S. D. ;

Wright, F. ;

Byrd, D. R. ;

Matter, M. ;

Hsueh, E. ;

MacKenzie-Ross, A. ;

Johnson, D. B. ;

Terheyden, P. ;

Berger, A. C. ;

Huston, T. L. ;

Wayne, J. D. ;

Smithers, B. M. ;

Neuman, H. B. ;

Schneebaum, S. ;

Gershenwald, J. E. ;

Ariyan, C. E. ;

Desai, D. C. ;

Jacobs, L. ;

McMasters, K. M. ;

Gesierich, A. ;

Hersey, P. ;

Bines, S. D. ;

Kane, J. M. ;

Barth, R. J. ;

McKinnon, G. ;

Farma, J. M. ;

Schultz, E. ;

Vidal-Sicart, S. ;

Hoefer, R. A. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (23) :2211-2222

[9] Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients [J].

Frankel, Arthur E. ;

Coughlin, Laura A. ;

Kim, Jiwoong ;

Froehlich, Thomas W. ;

Xie, Yang ;

Frenkel, Eugene P. ;

Koh, Andrew Y. .

NEOPLASIA, 2017, 19 (10) :848-855

[10] Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients [J].

Gopalakrishnan, V. ;

Spencer, C. N. ;

Nezi, L. ;

Reuben, A. ;

Andrews, M. C. ;

Karpinets, T. V. ;

Prieto, P. A. ;

Vicente, D. ;

Hoffman, K. ;

Wei, S. C. ;

Cogdill, A. P. ;

Zhao, L. ;

Hudgens, C. W. ;

Hutchinson, D. S. ;

Manzo, T. ;

de Macedo, M. Petaccia ;

Cotechini, T. ;

Kumar, T. ;

Chen, W. S. ;

Reddy, S. M. ;

Sloane, R. Szczepaniak ;

Galloway-Pena, J. ;

Jiang, H. ;

Chen, P. L. ;

Shpall, E. J. ;

Rezvani, K. ;

Alousi, A. M. ;

Chemaly, R. F. ;

Shelburne, S. ;

Vence, L. M. ;

Okhuysen, P. C. ;

Jensen, V. B. ;

Swennes, A. G. ;

McAllister, F. ;

Sanchez, E. Marcelo Riquelme ;

Zhang, Y. ;

Le Chatelier, E. ;

Zitvogel, L. ;

Pons, N. ;

Austin-Breneman, J. L. ;

Haydu, L. E. ;

Burton, E. M. ;

Gardner, J. M. ;

Sirmans, E. ;

Hu, J. ;

Lazar, A. J. ;

Tsujikawa, T. ;

Diab, A. ;

Tawbi, H. ;

Glitza, I. C. .

SCIENCE, 2018, 359 (6371) :97-103

← 1 2 3 4 →